RecruitingPhase 1Drug trialA Study Comparing Two Ways of Taking Olomorasib (LY3537982) in Healthy ParticipantsThe main purpose of this study is to compare how much and how quickly olomorasib gets into the bloodstream when it is taken in 2 different ways, and to check for any side effects. For each participant, the study will last about 6 weeks and will include 1 stay in the Clinical Research Unit (CRU) which consists of 7 nights.